RATIONALE: Traditionally, the therapeutic effect of antidepressants is thought to take several weeks. However, several studies found evidence of early drug response occurring within the first 2 weeks of antidepressant treatment and that this early onset response may predict eventual treatment outcome. OBJECTIVE: This study aims to investigate the predictive value of early improvement in the course of treatment with imipramine or venlafaxine in an inpatient population with severe major depression. METHOD: A post hoc analysis was conducted after pooling data from two almost identical trials. The study included 149 patients with DSM-IV diagnosis major depression and a baseline score ≥17 on the 17-item Hamilton Rating Scale for Depression (HAM-D). Patients were randomized for double-blind treatment with either antidepressant. Early improvement (≥25 % reduction on HAM-D score) was evaluated after 2 weeks and response (≥50 % reduction on HAM-D score) after 6 weeks of acute treatment. RESULTS: Of 64 patients achieving early improvement, 38 (59 %) became responders, whereas of 85 patients not achieving early improvement, only 23 (27 %) became responders. There was a significant difference in time to response between patients achieving early improvement and patients not achieving early improvement. Early improvement is a modest sensitive predictor for eventual response. CONCLUSION: In the present study, although the sensitivity of early improvement was modest, based on the severity of clinical symptoms, a clinician treating a patient with severe major depression may seriously consider changing the treatment at an earlier stage than is presently customary.
RCT Entities:
RATIONALE: Traditionally, the therapeutic effect of antidepressants is thought to take several weeks. However, several studies found evidence of early drug response occurring within the first 2 weeks of antidepressant treatment and that this early onset response may predict eventual treatment outcome. OBJECTIVE: This study aims to investigate the predictive value of early improvement in the course of treatment with imipramine or venlafaxine in an inpatient population with severe major depression. METHOD: A post hoc analysis was conducted after pooling data from two almost identical trials. The study included 149 patients with DSM-IV diagnosis major depression and a baseline score ≥17 on the 17-item Hamilton Rating Scale for Depression (HAM-D). Patients were randomized for double-blind treatment with either antidepressant. Early improvement (≥25 % reduction on HAM-D score) was evaluated after 2 weeks and response (≥50 % reduction on HAM-D score) after 6 weeks of acute treatment. RESULTS: Of 64 patients achieving early improvement, 38 (59 %) became responders, whereas of 85 patients not achieving early improvement, only 23 (27 %) became responders. There was a significant difference in time to response between patients achieving early improvement and patients not achieving early improvement. Early improvement is a modest sensitive predictor for eventual response. CONCLUSION: In the present study, although the sensitivity of early improvement was modest, based on the severity of clinical symptoms, a clinician treating a patient with severe major depression may seriously consider changing the treatment at an earlier stage than is presently customary.
Authors: Stephen K Brannan; Craig H Mallinckrodt; Michael J Detke; John G Watkin; Gary D Tollefson Journal: J Psychiatr Res Date: 2005-03 Impact factor: 4.791
Authors: Martin M Katz; Janet L Tekell; Charles L Bowden; Steve Brannan; John P Houston; Nancy Berman; Alan Frazer Journal: Neuropsychopharmacology Date: 2004-03 Impact factor: 7.853
Authors: Haoda Fu; Dachuang Cao; Kristina S Boye; Bradley Curtis; Dara L Schuster; David M Kendall; Haya Ascher-Svanum Journal: Diabetes Ther Date: 2015-07-05 Impact factor: 2.945
Authors: Antony Loebel; Leslie Citrome; Christoph U Correll; Jane Xu; Josephine Cucchiaro; John M Kane Journal: BMC Psychiatry Date: 2015-10-31 Impact factor: 3.630